Follow Us on Google
By Doris Obinna
Development of new MRI technologies has improved the survival rate of women diagnosed with breast cancer.
Dr. Chikara Nwoke, head, Healthcare PPC, said: “The breast cancer survival rate refers to the percentage of women living with cancer for at least five years after their diagnosis.
“Research indicates that nine out of 10 women are alive five years after they have been diagnosed with breast cancer.
“MRI devices are delivering more clinical information that oncologists need for diagnosis, follow-up examinations and treatment.
“A breast cancer diagnosis is no longer a death sentence for most women in the early stage of the disease, thanks to innovative treatment techniques and cutting-edge devices that make clinical interventions effective.
“MRI has emerged as a powerful diagnostic medical device due to its ability to provide high-resolution imaging of soft tissue and provide a wide range of image contrasts.
“It is, especially, useful in accurately defining tumour boundaries and contributing to the success rate of radiotherapy treatment of cancerous cells and image-guided surgery.
“Advanced MRI technology shortens the time radiologists spend during the scan as it speedily detects abnormal cells, freeing up time for hospitals to attend to other patients. The innovative device is being used by oncologists to monitor the effectiveness of chemotherapy and radiotherapy.”
Nwoke advocated regular screening and early detection of breast tumours to increase the survival rate of women with breast cancer.
